Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis.

Ann ChangShanzeh ChaudhryDaniel McCormackTara GomesAnisa ShivjiMina Tadrous

Published in: Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC (2022)

Ontario pharmacists used the CDSA exemption but were prescribing at low rates. These findings suggest an effective change to pharmacy practice as the low rates show pharmacists used the exemption as a last line of defense. This may lead to further studies exploring treatment breaks during the COVID-19 pandemic and future changes to pharmacist scope to benefit patients.

Keyphrases

primary care
end stage renal disease
coronavirus disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
general practice
chronic pain
drinking water
emergency department
pain management
adverse drug
combination therapy
replacement therapy